Compounds > 2,4-thiazolidinedione
Page last updated: 2024-11-05

2,4-thiazolidinedione and Carcinoma, Renal Cell

2,4-thiazolidinedione has been researched along with Carcinoma, Renal Cell in 1 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, K1
Kawahito, Y1
Tsubouchi, Y1
Kohno, M1
Yoshimura, R1
Yoshikawa, T1
Sano, H1

Other Studies

1 other study available for 2,4-thiazolidinedione and Carcinoma, Renal Cell

ArticleYear
Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
    Biochemical and biophysical research communications, 2001, Sep-28, Volume: 287, Issue:3

    Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Renal Cell; Cell Division; Chromans; Coloring A

2001